Michael Eric Smith - 17 Feb 2022 Form 4 Insider Report for Danimer Scientific, Inc. (DNMRQ)

Role
Chief Operating Officer
Signature
/s/ Michael Smith
Issuer symbol
DNMRQ
Transactions as of
17 Feb 2022
Net transactions value
-$7,700
Form type
4
Filing time
22 Feb 2022, 15:06:01 UTC
Previous filing
20 Jan 2022
Next filing
03 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNMR Class A Common Stock ("Common Stock") Options Exercise $32,800 +10,000 +2.9% $3.28 358,744 17 Feb 2022 Direct F1
transaction DNMR Common Stock Sale $40,500 -10,000 -2.8% $4.05 348,744 17 Feb 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNMR Stock Option (right to purchase) Options Exercise $0 -10,000 -1.6% $0.000000 608,909 17 Feb 2022 Common Stock 10,000 $3.28 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 348,744 restricted shares of the Common Stock granted under a previously disclosed restricted stock award.
F2 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Smith on June 25, 2021. The Reporting Person exercised no discretion with respect to the sale. Proceeds from the sale were used to pay the exercise price of stock options, pursuant to a broker-assisted cashless exercise, and applicable withholding taxes.
F3 The options are fully vested and currently exercisable.